ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,198,860 | -12.0% | 412,633 | -0.3% | 1.98% | -10.2% |
| Q2 2023 | $12,720,673 | +157.4% | 413,815 | +201.7% | 2.20% | +148.0% |
| Q1 2023 | $4,942,307 | -9.0% | 137,172 | -0.1% | 0.89% | -9.3% |
| Q4 2022 | $5,428,902 | -2.8% | 137,371 | -1.2% | 0.98% | -12.1% |
| Q3 2022 | $5,586,000 | -4.4% | 139,024 | +0.0% | 1.11% | -0.2% |
| Q2 2022 | $5,844,000 | +13.6% | 139,012 | +5.3% | 1.12% | +35.2% |
| Q1 2022 | $5,145,000 | -6.4% | 132,070 | -4.3% | 0.82% | +1.7% |
| Q4 2021 | $5,497,000 | – | 137,941 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |